Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Fludrocortisone Addition to Dexamethasone in the Management of Hospitalised COVID-19 Patients

NCT05453214 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05453214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05453214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Fludrocortisone Addition to Dexamethasone in the Management of Hospitalised COVID-19 Patients
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Completed
Start date
December 4, 2021
Completion date
June 20, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid-19